Page last updated: 2024-10-29

indomethacin and Granulocytic Leukemia, Chronic

indomethacin has been researched along with Granulocytic Leukemia, Chronic in 12 studies

Indomethacin: A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES.
indometacin : A member of the class of indole-3-acetic acids that is indole-3-acetic acid in which the indole ring is substituted at positions 1, 2 and 5 by p-chlorobenzoyl, methyl, and methoxy groups, respectively. A non-steroidal anti-inflammatory drug, it is used in the treatment of musculoskeletal and joint disorders including osteoarthritis, rheumatoid arthritis, gout, bursitis and tendinitis.

Research Excerpts

ExcerptRelevanceReference
"A patient with chronic myelogenous leukemia who developed arthritis secondary to IFN therapy is presented."2.40Alpha-interferon-induced arthritis: clinical presentation treatment, and prevention. ( Nesher, G; Ruchlemer, R, 1998)
"Indomethacin (IN) can inhibit cyclooxygenase activity and is considered to exert antitumor action in a variety of cancer cells."1.33Antiproliferative effect of indomethacin on CML cells is related to the suppression of STATs/Bcl-XL signal pathway. ( Fu, Y; Zhang, G, 2006)
" 0 approximately 400 micromol/L of IN could down-regulate the expression of p-STAT1 or p-STAT5 in a dose-response manner, p-STATs were distributed mainly in the nucleus as scattering spots."1.32[Proliferation inhibition effect of indomethacin on CML cells associated with down-regulation of phosphorylated STAT1/STAT5 and inhibition of COX-2 expression]. ( Fu, YB; Xia, M; Zhang, GS, 2004)
"The hallmark of chronic myeloid leukemia (CML) is the presence of the bcr-abl oncogene, which is associated with transforming ability and an intrinsic resistance to induction of apoptosis by genotoxic agents."1.30Induction of apoptosis by arachidonic acid in chronic myeloid leukemia cells. ( Akard, L; Boswell, HS; Carlo-Stella, C; Dugan, M; Garau, D; Regazzi, E; Rizzo, MT; Rizzoli, V, 1999)
"Treatment with indomethacin briefly improved the symptoms, but within 72 hours the patient developed a fulminant illness with high fever and clinical as well as biochemical signs of a severe consumption coagulopathy."1.28[Atypical joint symptoms as initial symptoms of varicella infection in chronic myeloid leukemia]. ( Arning, M; Aul, C; Bürrig, KF; Reinecke, P; Schneider, W, 1990)

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (41.67)18.2507
2000's5 (41.67)29.6817
2010's2 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Heidel, FH1
Bullinger, L1
Feng, Z1
Wang, Z1
Neff, TA1
Stein, L1
Kalaitzidis, D1
Lane, SW1
Armstrong, SA1
Cipák, L1
Paulíková, H1
Novotný, L1
Jarosová, M1
Rauko, P1
Fu, YB2
Zhang, GS2
Xia, M1
Zhang, G4
Fu, Y1
Nesher, G1
Ruchlemer, R1
Rizzo, MT1
Regazzi, E1
Garau, D1
Akard, L1
Dugan, M1
Boswell, HS1
Rizzoli, V1
Carlo-Stella, C1
Tu, C2
Zhou, G1
Zheng, W1
Lu, H1
Maca, RD1
Arning, M1
Aul, C1
Reinecke, P1
Bürrig, KF1
Schneider, W1

Reviews

1 review available for indomethacin and Granulocytic Leukemia, Chronic

ArticleYear
Alpha-interferon-induced arthritis: clinical presentation treatment, and prevention.
    Seminars in arthritis and rheumatism, 1998, Volume: 27, Issue:6

    Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Antinuclear; Antineop

1998

Other Studies

11 other studies available for indomethacin and Granulocytic Leukemia, Chronic

ArticleYear
Genetic and pharmacologic inhibition of β-catenin targets imatinib-resistant leukemia stem cells in CML.
    Cell stem cell, 2012, Apr-06, Volume: 10, Issue:4

    Topics: Animals; Antineoplastic Agents; Benzamides; beta Catenin; Cyclooxygenase Inhibitors; Drug Resistance

2012
β-catenin inhibition synergizes with imatinib to delay CML recurrence.
    Cancer discovery, 2012, Volume: 2, Issue:6

    Topics: Animals; Antineoplastic Agents; beta Catenin; Cyclooxygenase Inhibitors; Drug Resistance, Neoplasm;

2012
Potentiation of doxorubicin-induced apoptosis and differentiation by indomethacin in K-562 leukemia cells.
    Neoplasma, 2004, Volume: 51, Issue:3

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibiotics, Antineoplastic; Apoptosis; Cell Differentiatio

2004
[Proliferation-inhibiting effect of indomethacin on chronic myeliod leukemia cells is related to the supression of STAT signal transduction pathway].
    Zhongguo shi yan xue ye xue za zhi, 2004, Volume: 12, Issue:6

    Topics: Antineoplastic Agents; Blotting, Western; Cell Proliferation; Dose-Response Relationship, Drug; Fluo

2004
[Proliferation inhibition effect of indomethacin on CML cells associated with down-regulation of phosphorylated STAT1/STAT5 and inhibition of COX-2 expression].
    Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2004, Volume: 25, Issue:12

    Topics: bcl-X Protein; Blotting, Western; Cell Proliferation; Cyclooxygenase 2; Cyclooxygenase Inhibitors; D

2004
Antiproliferative effect of indomethacin on CML cells is related to the suppression of STATs/Bcl-XL signal pathway.
    Annals of hematology, 2006, Volume: 85, Issue:7

    Topics: bcl-X Protein; Cell Division; Humans; Indomethacin; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-

2006
Induction of apoptosis by arachidonic acid in chronic myeloid leukemia cells.
    Cancer research, 1999, Oct-01, Volume: 59, Issue:19

    Topics: 5,8,11,14-Eicosatetraynoic Acid; Adult; Animals; Antioxidants; Apoptosis; Arachidonic Acid; Bone Mar

1999
Indomethacin induces apoptosis and inhibits proliferation in chronic myeloid leukemia cells.
    Leukemia research, 2000, Volume: 24, Issue:5

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; bcl-2-Associated X Protein; Cell Division

2000
[Study of apoptosis induced by indomethacin in chronic myeloid leukemia].
    Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 1999, Volume: 20, Issue:7

    Topics: Apoptosis; Down-Regulation; Humans; Indomethacin; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-AB

1999
Enhancement of etoposide and methotrexate sensitivity by indomethacin in vitro.
    Anti-cancer drug design, 1991, Volume: 6, Issue:5

    Topics: Animals; Bleomycin; Drug Synergism; Etoposide; Humans; Indomethacin; Leukemia, Myelogenous, Chronic,

1991
[Atypical joint symptoms as initial symptoms of varicella infection in chronic myeloid leukemia].
    Deutsche medizinische Wochenschrift (1946), 1990, Oct-19, Volume: 115, Issue:42

    Topics: Adult; Chickenpox; Female; Hip Joint; Humans; Indomethacin; Joint Diseases; Leukemia, Myelogenous, C

1990